Legal & General Group’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$466K Sell
104,308
-28,838
-22% -$134K ﹤0.01% 2369
2025
Q4
$732K Buy
133,146
+109,997
+475% +$534K ﹤0.01% 2307
2025
Q3
$75.7K Buy
23,149
+4,754
+26% +$13.5K ﹤0.01% 2664
2025
Q2
$42.5K Sell
18,395
-1,563
-8% -$3.4K ﹤0.01% 2744
2025
Q1
$27.7K Sell
19,958
-60
-0.3% -$100 ﹤0.01% 2833
2024
Q4
$34.6K Hold
20,018
﹤0.01% 2852
2024
Q3
$40.2K Buy
20,018
+2,093
+12% +$4.59K ﹤0.01% 2828
2024
Q2
$40.2K Buy
+17,925
New +$52.2K ﹤0.01% 2824
2022
Q2
Sell
-16,100
Closed -$104K 3656
2022
Q1
$104K Hold
16,100
﹤0.01% 2852
2021
Q4
$187K Buy
16,100
+8,993
+127% +$136K ﹤0.01% 2747
2021
Q3
$132K Buy
7,107
+3,358
+90% +$63.8K ﹤0.01% 2793
2021
Q2
$80K Buy
3,749
+2,835
+310% +$65.3K ﹤0.01% 2806
2021
Q1
$18K Hold
914
﹤0.01% 3178
2020
Q4
$24K Buy
914
+14
+2% +$302 ﹤0.01% 3024
2020
Q3
$20K Buy
+900
New +$21.2K ﹤0.01% 2973

Other funds holding TSHA